Skip to main content
Clinical Trials/NCT01891760
NCT01891760CompletedPhase 3

A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial

Shire Regenerative Medicine, Inc.56 sites in 6 countries225 target enrollmentStarted: May 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
225
Locations
56
Primary Endpoint
The incidence of study ulcer recurrence

Study Overview

Brief Summary

  • Observe the long-term (1-year) outcomes of Dermagraft, compared with conventional treatment of four-layer compression bandaging therapy alone, in subjects who completed the ABH-Dermagraft-001-08 study.
  • Study Hypothesis: N/A (Long-term follow-up study)

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject has completed study ABH-Dermagraft-001-08
  • Subject understands study requirements
  • Subject is available to participate in the 1 year-long observational follow-up.

Exclusion Criteria

  • Subject who withdrew or was terminated from ABH-Dermagraft-001-08 before completion
  • Subject is not available for the 1 year-long observational period.
  • Subject has any condition(s) which seriously compromises the subject's ability to complete the study

Outcomes

Primary Outcomes

The incidence of study ulcer recurrence

Time Frame: 1 year

Secondary Outcomes

  • Incidence of complete study ulcer healing(1 year)
  • Incidence of study ulcer infection-related events(1 year)
  • Time to study ulcer recurrence(1 year)
  • Change in ulcer size(1 year)
  • Time to study ulcer healing(1 year)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (56)

Loading locations...

Similar Trials